Department for Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska University Hospital, Huddinge, Sweden.
Am J Hypertens. 2014 Apr;27(4):579-85. doi: 10.1093/ajh/hpt140. Epub 2013 Aug 16.
Post-transplant hypertension impacts negatively on renal graft survival. Our primary objective was to analyze the effect of hypertension on the glomerular filtration rate (GFR) slope.
All clinical charts of children who underwent renal transplantation since the introduction of the routine use of ambulatory blood pressure monitoring (ABPM) were reviewed. Eligibility criteria for inclusion were measurement of GFR at 3 months, at 1 year post-transplant, and thereafter at yearly intervals; ABPM performed annually after transplantation; and functioning graft for a minimum of 2 years.
Sixty-eight (39 males) of 79 patients, aged 9.1±5.3 years, met the inclusion criteria. The mean follow-up was 6.2±2.8 years. Twenty-four patients had normotension or controlled hypertension throughout their follow-up (normotensive group). Forty-four patients had hypertension or noncontrolled hypertension at some point(s) during the follow-up period (hypertensive group). GFR slope was -1.6ml/min/1.73 m(2) per year (95% confidence interval (CI = -3.7 to 0.4) in the normotensive group and -2ml/min/1.73 m(2) per year (95% CI = -3 to -1.1) in the hypertensive group (P = 0.42). There was no difference between groups with regard to the change in GFR values from 3 months to 1 year and to last control (P = 0.87). At most recent control, the overall prevalence of controlled hypertension was 78.2% (95% CI = 63.6-89.1).
Although the results of our study are encouraging, they need to be confirmed in a larger prospective study using the same post-transplant follow-up protocol.
移植后高血压会对肾移植物的存活率产生负面影响。我们的主要目的是分析高血压对肾小球滤过率(GFR)斜率的影响。
回顾了自常规使用动态血压监测(ABPM)以来接受肾移植的所有儿童的临床病历。纳入标准为:在移植后 3 个月、1 年和此后每年至少 2 年测量 GFR;移植后每年进行 ABPM;并且移植物功能正常。
79 例患者中,68 例(39 名男性)符合纳入标准,年龄为 9.1±5.3 岁。平均随访时间为 6.2±2.8 年。24 例患者在整个随访期间血压正常或高血压得到控制(血压正常组)。44 例患者在随访期间的某个时间点出现高血压或未控制的高血压(高血压组)。GFR 斜率在血压正常组为每年-1.6ml/min/1.73 m2(95%可信区间(CI)为-3.7 至 0.4),在高血压组为每年-2ml/min/1.73 m2(95% CI 为-3 至-1.1)(P = 0.42)。两组间从 3 个月到 1 年和最后一次控制的 GFR 值变化无差异(P = 0.87)。在最近的一次控制中,总体上控制良好的高血压患病率为 78.2%(95% CI = 63.6-89.1)。
尽管我们的研究结果令人鼓舞,但需要在使用相同移植后随访方案的更大前瞻性研究中加以证实。